Natural Foods for the Treatment of Nonalcoholic Fatty Liver Disease
- 1 January 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Medicinal Food
- Vol. 26 (1), 1-13
- https://doi.org/10.1089/jmf.2022.k.0052
Abstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The etiology of NAFLD is highly heterogeneous, which occurs and develops under the joint action of metabolism, inflammation, genetics, environment, and gut microbiota. At present, the principal therapeutic modalities targeting NAFLD are lifestyle interventions such as weight loss through diet and exercise. At present, there is no established therapy for the treatment of NAFLD, and many therapies are associated with a variety of side effects. A great number of in vitro and in vivo experiments have indicated that there are many natural foods that have therapeutic potential for NAFLD. This review summarizes the natural foods and their mechanisms that were found in recent years, furthermore, provides further information relevant to the treatment of NAFLD.Keywords
This publication has 87 references indexed in Scilit:
- Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activationBiochemical Pharmacology, 2013
- Study of the Effects of Monacolin K and Other Constituents of Red Yeast Rice on Obesity, Insulin-Resistance, Hyperlipidemia, and Nonalcoholic Steatohepatitis Using a Mouse Model of Metabolic SyndromeEvidence-Based Complementary and Alternative Medicine, 2012
- The natural carotenoid astaxanthin, a PPAR‐α agonist and PPAR‐γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid‐loaded hepatocytesMolecular Nutrition & Food Research, 2012
- Chlorogenic Acid Exhibits Cholesterol Lowering and Fatty Liver Attenuating Properties by Up‐regulating the Gene Expression of PPAR‐α in Hypercholesterolemic Rats Induced with a High‐Cholesterol DietPhytotherapy Research, 2012
- Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal modelEuropean Journal of Nutrition, 2012
- An intervention study in obese mice with astaxanthin, a marine carotenoid – effects on insulin signaling and pro-inflammatory cytokinesFood & Function, 2011
- Effects of Astaxanthin on Oxidative Stress in Overweight and Obese AdultsPhytotherapy Research, 2011
- Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered ratsEuropean Journal of Pharmacology, 2010
- Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidemia: A preliminary reportEuropean Journal of Internal Medicine, 2009
- Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptorJournal of Lipid Research, 2008